Literature DB >> 20585325

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.

M Herberth1, D Koethe, T M K Cheng, N D Krzyszton, S Schoeffmann, P C Guest, H Rahmoune, L W Harris, L Kranaster, F M Leweke, S Bahn.   

Abstract

Little is known about the biological mechanisms underpinning the pathology of schizophrenia. We have analysed the proteome of stimulated and unstimulated peripheral blood mononuclear cells (PBMCs) from schizophrenia patients and controls as a potential model of altered cellular signaling using liquid-chromatography mass spectrometry proteomic profiling. PBMCs from patients and controls were stimulated for 72 h in vitro using staphylococcal enterotoxin B. In total, 18 differentially expressed proteins between first-onset, antipsychotic-naive patients and controls in the unstimulated and stimulated conditions were identified. Remarkably, eight of these proteins were associated with the glycolytic pathway and patient-control differences were more prominent in stimulated compared with unstimulated PBMCs. None of these proteins were altered in chronically ill antipsychotic-treated patients. Non-linear multivariate statistical analysis showed that small subsets of these proteins could be used as a signal for distinguishing first-onset patients from controls with high precision. Functional analysis of PBMCs did not reveal any difference in the glycolytic rate between patients and controls despite increased levels of lactate and the glucose transporter-1, and decreased levels of the insulin receptor in patients. In addition, subjects showed increased serum levels of insulin, consistent with the idea that some schizophrenia patients are insulin resistant. These results show that schizophrenia patients respond differently to PBMC activation and this is manifested at disease onset and may be modulated by antipsychotic treatment. The glycolytic protein signature associated with this effect could therefore be of diagnostic and prognostic value. Moreover, these results highlight the importance of using cells for functional discovery and show that it may not be sufficient to measure protein expression levels in static states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585325     DOI: 10.1038/mp.2010.71

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  30 in total

1.  Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2016-05-11       Impact factor: 9.306

2.  Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.

Authors:  Robert Cunningham; Di Ma; Lingjun Li
Journal:  Front Biol (Beijing)       Date:  2012-08-01

Review 3.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics.

Authors:  Chi-Yu Lai; Elizabeth Scarr; Madhara Udawela; Ian Everall; Wei J Chen; Brian Dean
Journal:  World J Psychiatry       Date:  2016-03-22

Review 4.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

Review 5.  Astrocyte Bioenergetics and Major Psychiatric Disorders.

Authors:  Ivan V Maly; Michael J Morales; Mikhail V Pletnikov
Journal:  Adv Neurobiol       Date:  2021

6.  Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia.

Authors:  Yuan Gao; Yajuan Fan; Zai Yang; Qingyan Ma; Binbin Zhao; Xiaoyan He; Fengjie Gao; Li Qian; Wei Wang; Ce Chen; Yunchun Chen; Chengge Gao; Xiancang Ma; Feng Zhu
Journal:  Mol Psychiatry       Date:  2021-11-02       Impact factor: 15.992

7.  Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia.

Authors:  Cigdem Sahbaz; Noushin Zibandey; Ayse Kurtulmus; Yazgul Duran; Muazzez Gokalp; Ismet Kırpınar; Fikrettin Sahin; Sinan Guloksuz; Tunc Akkoc
Journal:  Psychopharmacology (Berl)       Date:  2020-03-27       Impact factor: 4.530

8.  Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.

Authors:  Jason D Cooper; Sureyya Ozcan; Renee M Gardner; Nitin Rustogi; Susanne Wicks; Geertje F van Rees; F Markus Leweke; Christina Dalman; Håkan Karlsson; Sabine Bahn
Journal:  Transl Psychiatry       Date:  2017-12-18       Impact factor: 6.222

9.  The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review.

Authors:  Jobbe Goossens; Manuel Morrens; Violette Coppens
Journal:  Mol Diagn Ther       Date:  2021-05-12       Impact factor: 4.074

10.  Association between ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients.

Authors:  Yongfeng Yang; Wenqiang Li; Jingyuan Zhao; Hongxing Zhang; Xueqin Song; Bo Xiao; Ge Yang; Chengdi Jiang; Dai Zhang; Weihua Yue; Luxian Lv
Journal:  Behav Brain Funct       Date:  2012-02-28       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.